Henry Ford Health System is the only hospital system in Michigan chosen as a Phase 3 trial site for the Moderna mRNA-1273 Coronavirus Efficacy (COVE) vaccine study, the National Institutes of Health announced Monday.
Henry Ford is enrolling volunteers into this randomized double-blind study of whether a two-dose vaccine prevents COVID-19 infection in those exposed to the coronavirus.
